Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kaprolac K301 for seborrhoeic dermatitis of the scalp
2007-006188-59Phase 3Completed
- Sponsor
- Moberg Pharma AB
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in seborrheic dermatitis (SD) comparing Kaprolac K301 with Placebo (2 arms). Started Nov 2007; status: completed.
02
Drugs
Kaprolac
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on 2007-006188-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006188-59.